Despite the negative impact from the coronavirus and the Chinese economic downturn, Asia Pacific will have 417 million SVOD subscriptions by 2025, up from 269 million in 2019.
China will have 269 million SVOD subscriptions in 2025 - or 65% of the region's total. India will supply a further 45 million - more than double its 2019 total.
Three Chinese companies will top the Asia Pacific SVOD subscriber rankings in 2025 - with two recording 100 million subscribers. Never expected to operate as standalone platforms in China, Netflix and Amazon Prime Video will take fourth and fifth places respectively.
Simon Murray, a Principal Analyst, said: China will also dominate the SVOD revenue rankings. The top five platforms [Tencent Video, Iqiyi, Netflix, Disney+ and Youku Tudou] will account for two-thirds of the region's SVOD revenues by 2025.
Key Topics Covered:
Published in March 2020, this 212-page PDF, PowerPoint and excel report provides extensive research for 22 territories. Covering movies and TV episodes, the report comes in three parts:
Outlook: Forecasts for 22 countries in a 49-page PowerPoint document full of charts, graphs and bullet points;
Excel workbook covering each year from 2010 to 2025 for 22 countries by household penetration, by SVOD subscribers and by OTT revenues for movies and TV episodes. As well as summary tables by country and by platform;
Insight: Detailed country-by-country analysis in a 96-page PDF document.
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....